What is ERIS Lifesciences Ltd (ERIS) share price today?

ERIS Lifesciences Ltd (ERIS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/ERIS for the latest live price, technical analysis, and AI-powered insights.

How to analyse ERIS stock?

VestAI provides comprehensive ERIS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is ERIS Lifesciences Ltd in?

ERIS Lifesciences Ltd (ERIS) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

ERIS Lifesciences Ltd

Q: What is ERIS Lifesciences Ltd's Orion Score?

ERIS Lifesciences Ltd has an Orion Score of 62/100 (Watch) — a fundamentals-based quality & risk score. ERIS Lifesciences Ltd scores 62/100 (Watch) on the Orion Score — moderate business quality (67), strong growth (85), weak balance-sheet safety (45) and rich valuation (37). A fundamentals-based quality & risk score, not a buy/sell recommendation.

ERIS

NSE· Healthcare

₹1,451.10

-2.00 (-0.14%)

Updated 07:29 am IST

52W Low · ₹1,200.0052W High · ₹1,885.00

Mid Range

Market Cap

₹18917.20L Cr

Volume

83.1K

Prev Close

₹1,449.90

ISIN

INE406M01024

Orion Score

Fundamentals-based quality & risk · not a recommendation

62/100

Watch

ERIS Lifesciences Ltd scores 62/100 (Watch) on the Orion Score — moderate business quality (67), strong growth (85), weak balance-sheet safety (45) and rich valuation (37). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.3× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 5/9Altman Z Safe(4.73)Beneish M Elevated(-1.92)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

51/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Moderate

D/E 0.61x — manageable leverage

QUALITY

Average

ROCE 15.9% — decent returns

MOMENTUM

Neutral

RSI 58.0 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 30.12
ROCE: 15.89%
ROE (1Y): 18.07%
D/E Ratio: 0.61x
OPM: 27.13%
TTM EPS: ₹45.32
Dividend Yield: 106.00%
Qtrly Sales: ₹752.29 Cr
Qtrly Profit: ₹281.61 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹752.29	₹281.61	27.1%	₹20.57
Q3 2026	₹800.89	₹99.72	26.4%	₹7.32
Q2 2026	₹790.15	₹120.19	27.7%	₹8.81
Q1 2026	₹771.56	₹117.99	26.7%	₹8.64
Q4 2025	₹702.6	₹93.84	24.9%	₹6.89

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹2,879.26	₹351.84	₹1,035.62	24.4%
FY 2024	₹1,991.3	₹392.05	₹698.65	24.9%
FY 2023	₹1,661.82	₹382.16	₹547.9	25.4%
FY 2022	₹1,326.17	₹406.11	₹511.05	32.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
ERIS ★	₹18,917 Cr	30.12	15.89%	18.07%	0.61x	27.13%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹7,033.17	₹7,040.46	₹3,667.33	₹2,272.14
Equity	₹2,854.36	₹2,586.18	₹2,195.99	₹1,908.31
Total Debt	₹2,477.92	₹2,781.28	₹876.71	₹84.41
Cash	₹199.64	₹94.14	₹55.95	₹50.87
Net Debt	₹2,222.02	₹2,641.14	₹774.07	—
Working Capital	₹-158.4	₹-230.03	₹321.49	₹427.68

Shareholding Pattern

Q1 FY2027

Promoter

69.7%

FII

12.41%

DII

10.15%

Public

7.74%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	69.7% ↑	12.41% ↑	10.15% ↑	7.74% ↓
Q4 FY2026	68.05% ↑	12.02% ↑	9.84% ↓	10.09% ↓
Q3 FY2026	54.85%	6.85% ↓	20.31% ↑	17.97% ↓
Q2 FY2026	54.85% ↑	7.21% ↓	19.36% ↑	18.57% ↓
Q1 FY2026	54.83% ↓	8.39% ↓	18.18% ↑	18.59% ↓
Q4 FY2025	54.85%	8.43% ↑	18.07%	18.64% ↓
Q3 FY2025	54.86%	8.36% ↑	18.07% ↓	18.73% ↑
Q2 FY2025	54.87%	8.01%	18.64%	18.47%

Corporate Actions

Ex-Date	Action	Details
2026-05-29	DIVIDEND	Interim Dividend - Rs 7.21 Per Share

Funds Holding This Stock

77 mutual fund schemes

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

3.25%

₹100 Cr

Motilal Oswal Innovation Opportunities Fund Direct GrowthMOTILAL_OSWAL

3.03%

₹17 Cr

Bank of India Consumption Fund Direct GrowthBOI_AXA

2.91%

₹11 Cr

HDFC Small Cap Fund Direct GrowthHDFC

2.37%

₹920 Cr

Bank of India Multi Cap Fund Direct GrowthBOI_AXA

2.33%

₹26 Cr

Franklin India Small Cap Fund Direct GrowthFRANKLIN_TEMPLETON

2.26%

₹313 Cr

Bank of India Manufacturing & Infrastructure Fund Direct GrowthBOI_AXA

2.23%

₹18 Cr

Bank of India Large & Mid Cap Fund Direct GrowthBOI_AXA

2.15%

₹10 Cr

Quantum Small Cap Fund Direct GrowthQUANTUM

2.09%

₹5 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

2.04%

₹6 Cr

Analyse ERIS with Orion AI

Ask: "Is ERIS Lifesciences Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About ERIS Lifesciences Ltd (ERIS) Stock

ERIS Lifesciences Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE406M01024. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.